Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by Engcan77on Jan 02, 2018 1:20am

121 Views

Post# 27259199

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Howard; you have some explaining to do

Putin. I believe most of us have tried to contact management many times. Sometimes we get an answer that 'we are confident' etc etc.
Glad to hear that you believe the 1067 deal isn't dead. I believe in the long run, the SGLT2 deal could be huge for the company. However this could be couple of years away. We need a 1067 deal quickly to get the company cash to continue all the other projects. Or there will probably be more dilution with more PP's.
Many of us have been waitin 5+ years already. Hopefully we don't have to wait another 2 years to see this get can out of the 5 to 25 cent range!!!! Although .25 cents looks pritt-stick good right now.lol

Bullboard Posts

Changing Europe’s dependency on HREE from China